BioSpace News Archive

Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced that the first patient successfully received LV-RAG1 ex vivo lentiviral gene therapy to treat recombinase-activating gene-1 (“RAG1”) severe combined immunodeficiency.

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review and filed its New Drug Application (NDA) for sotagliflozin.

MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced the formation of a Regenerative Medicine Scientific Advisory Board.

Fresenius Medical Care North America’s (FMCNA) Renal Therapies Group today announced the availability of the CombiSet SMARTECH TM.

Thomas D. Fagan Jr. Appointed Vice President, U.S. Alzheimer’s Disease Commercial at Eisai Inc.

Revance Therapeutics, Inc. today announced the presentation of six abstracts to be presented at the 2022 TOXINS International Conference on July 27-30, 2022 in New Orleans, Louisiana.

Bracco Diagnostics Inc., a U.S. subsidiary of Bracco Imaging S.p.A., one of the world’s leading companies in the diagnostic imaging business, announced that the U.S. Food and Drug Administration (FDA) granted import discretion of Iomeron ® (iomeprol injection) into the U.S. to address the ongoing iodinated contrast media shortage.

Agilent Technologies Inc. (NYSE: A) announced today that Stefanos Nikolaidis Ph.D. has received the Agilent 2022 Early Career Professor Award.

Plandai Biotechnology, Inc. announces the termination of its non-binding letter of intent dated May 23, 2022, with Ms. Jessie Chiang, license holder of the worldwide rights, exclusive of Taiwan, of the Puriblood Leukocyte Reduction Blood Filtration System.

Wilmington, Delaware, United States, Transparency Market Research Inc.: Carrier screening is a genetic test used to determine if a healthy person is a carrier of a recessive genetic disease or a gene for certain genetic disorders.